Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1518135953
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1520 San Pablo St, Suite 3000
Los Angeles, CA, 90033
Phone (323) 442-5710
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,793
296 services
Medicare patients, 2024
22
Average age 65
Drug cost, 2024
$752K
2,961 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Lee Lin prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 803 prescriptions and refills. In total Lee Lin wrote 2,961 Medicare prescriptions that cost $752K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 803 | 2,458 | 269 | $65K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 215 | 670 | 74 | $16K |
| Gabapentin Generic | 105 | 313 | 42 | $2,423 |
| Carbidopa Generic | 102 | 255 | 35 | $12K |
| Rytary Carbidopa/Levodopa | 93 | 273 | 23 | $243K |
| Levetiracetam Generic | 82 | 241 | 26 | $3,529 |
| Amantadine Amantadine Hcl | 81 | 234 | 24 | $2,645 |
| Rasagiline Mesylate Generic | 78 | 240 | 27 | $17K |
| Clonazepam Generic | 69 | 69 | 14 | $507 |
| Mirtazapine Generic | 67 | 217 | 25 | $1,123 |
| Topiramate Generic | 49 | 150 | 20 | $978 |
| Primidone Generic | 48 | 149 | 21 | $1,852 |
| Atropine Sulfate Generic | 48 | 48 | Under 11 | $1,377 |
| Donepezil Hcl Generic | 46 | 141 | 20 | $730 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 45 | 130 | 13 | $942 |
Brand drugs: - claims; generic drugs: 2,640 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Lee Lin were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.